Marker Therapeutics (MRKR) Other Accumulated Expenses (2010 - 2026)
Marker Therapeutics (MRKR) reported Other Accumulated Expenses of $804,795 for Q2 2026, up 22.6% from $656,631 a year earlier but down 19.6% from the prior quarter.
Powered by 
Analysis
Marker Therapeutics (MRKR) Other Accumulated Expenses (2010 - 2026) Analysis & Trends
At the end of FY2024, Marker Therapeutics posted Other Accumulated Expenses of $1.71 million, up 28.6% from FY2023.
- Other Accumulated Expenses has a five-year compound annual growth rate of 47.7% (FY2019 to FY2024).
- By year, Other Accumulated Expenses came in at $1.33 million in FY2023, $38,000 in FY2022 (-84.8%), $250,000 in FY2021 (+96.9%) and $127,000 in FY2020 (-47.7%).
- Five-year quarterly Other Accumulated Expenses spans a low of $38,000 in Q4 2022 and a high of $1.71 million in Q4 2024.
- Year over year, Other Accumulated Expenses gained in six of the last seven quarters, with growth averaging 56.7%.
- The high point for year-over-year Other Accumulated Expenses in five years was Q1 2026 (growth of 143.4%); the low point was Q4 2022 (a decline of 84.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Marker Therapeutics | 17.53 Mn | -42.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 804,795.00 |
| Mar 31, 2026 | 1.00 Mn |
| Sep 30, 2025 | 328,315.00 |
| Jun 30, 2025 | 656,631.00 |
| Mar 31, 2025 | 411,327.00 |
| Dec 31, 2024 | 1.71 Mn |
| Sep 30, 2024 | 903,438.00 |
| Jun 30, 2024 | 293,000.00 |
| Mar 31, 2024 | 354,000.00 |
| Dec 31, 2023 | 1.33 Mn |
| Sep 30, 2023 | 400,000.00 |
| Jun 30, 2023 | 196,000.00 |
| Mar 31, 2023 | 295,000.00 |
| Dec 31, 2022 | 38,000.00 |
| Sep 30, 2022 | 305,000.00 |
| Jun 30, 2022 | 305,000.00 |
| Mar 31, 2022 | 241,000.00 |
| Dec 31, 2021 | 250,000.00 |
| Sep 30, 2021 | 359,000.00 |
| Jun 30, 2021 | 432,000.00 |
API Access
Marker Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=MRKR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "MRKR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=MRKR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();